The Centers for Disease Control and Prevention (CDC), in collaboration with the Food and Drug Administration (FDA), state public health departments, and state boards of pharmacy, is investigating the outbreak which has been identified as fungal meningitis. The outbreak does not appear to have been caused by improper infection control practices by healthcare providers who administered the medication.
It is important for all clinicians to monitor and stay informed about this ongoing outbreak. AANA has compiled resources about the outbreak and other pertinent information regarding infection control practices that are essential to our patients’ safety.
In the News
- Exserohilum Infections Associated with Contaminated Steroid Injections: A Clinicopathologic Review of 40 Cases, The American Journal of Pathology, June 26, 2013
Centers for Disease Control and Prevention
CDC Health Alert Network
CDC Morbidity and Mortality Weekly Report (MMWR)
Food and Drug Administration
Other Important Infection Control Resources